Modeling of intracellular processes occurring during the development of Alzheimer's disease (AD) can be instrumental in understanding the disease and can potentially contribute to finding treatments for the disease. The model of intracellular processes in AD, which we previously developed, contains a large number of parameters. To distinguish between more important and less important parameters, we performed a local sensitivity analysis of this model around the values of parameters that give the best fit with published experimental results. We show that the influence of model parameters on the total concentrations of amyloid precursor protein (APP) and tubulin-associated unit (tau) protein in the axon is reciprocal to the influence of the same parameters on the average velocities of the same proteins during their transport in the axon. The results of our analysis also suggest that in the beginning of AD the aggregation of amyloid-β and misfolded tau protein have little effect on transport of APP and tau in the axon, which suggests that early damage in AD may be reversible.
Issue Section:
Research Papers
References
1.
Hardy
, J.
, 2006
, “A Hundred Years of Alzheimer's Disease Research
,” Neuron
, 52
(1
), pp. 3
–13
.2.
Maqbool
, M.
, Mobashir
, M.
, and Hoda
, N.
, 2016
, “Pivotal Role of Glycogen Synthase Kinase-3: A Therapeutic Target for Alzheimer's Disease
,” Eur. J. Med. Chem.
, 107
, pp. 63
–81
.3.
Hung
, S.
, and Fu
, W.
, 2017
, “Drug Candidates in Clinical Trials for Alzheimer's Disease
,” J. Biomed. Sci.
, 24
(1
), p. 47
.4.
Kumar
, A.
, Singh
, A.
, and Ekavali
, 2015
, “A Review on Alzheimer's Disease Pathophysiology and Its Management: An Update
,” Pharmacol. Rep.
, 67
(2
), pp. 195
–203
.5.
Scheltens
, P.
, Blennow
, K.
, and Breteler
, M. M. B.
, 2016
, “Alzheimer's Disease
,” Lancet
, 388
(10043
), pp. 505
–517
.6.
Wang
, J.
, Gu
, B. J.
, and Masters
, C. L.
, 2017
, “A Systemic View of Alzheimer Disease—Insights From Amyloid-Beta Metabolism Beyond the Brain
,” Nat. Rev. Neurol.
, 13
(10
), pp. 612
–623
.7.
Qiu
, C.
, and Fratiglioni
, L.
, 2017
, “Epidemiology of Alzheimer's Disease
,” G.
Waldemar
and A.
Burns
, eds., Oxford University Press
, Oxford, UK
, pp. 17
–26
.8.
Vehmas
, A.
, Kawas
, C.
, and Stewart
, W.
, 2003
, “Immune Reactive Cells in Senile Plaques and Cognitive Decline in Alzheimer's Disease
,” Neurobiol. Aging
, 24
(2
), pp. 321
–331
.9.
Hardy
, J. A.
, and Higgins
, G. A.
, 1992
, “Alzheimers-Disease—The Amyloid Cascade Hypothesis
,” Science
, 256
(5054
), pp. 184
–185
.10.
Hardy
, J.
, and Selkoe
, D.
, 2002
, “The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
,” Science
, 297
(5580
), pp. 353
–356
.11.
Selkoe
, D. J.
, and Hardy
, J.
, 2016
, “The Amyloid Hypothesis of Alzheimer's Disease at 25 Years
,” EMBO Mol. Med.
, 8
(6
), pp. 595
–608
.12.
Lemere
, C. A.
, and Masliah
, E.
, 2010
, “Can Alzheimer Disease Be Prevented by Amyloid-Beta Immunotherapy?
,” Nat. Rev. Neurol.
, 6
(2
), pp. 108
–119
.13.
Herrup
, K.
, 2015
, “The Case for Rejecting the Amyloid Cascade Hypothesis
,” Nat. Neurosci.
, 18
(6
), pp. 794
–799
.14.
Karran
, E.
, Mercken
, M.
, and De Strooper
, B.
, 2011
, “The Amyloid Cascade Hypothesis for Alzheimer's Disease: An Appraisal for the Development of Therapeutics
,” Nat. Rev. Drug Discovery
, 10
(9
), pp. 698
–712
.15.
Panza
, F.
, Logroscino
, G.
, and Imbimbo
, B. P.
, 2014
, “Is There Still Any Hope for Amyloid-Based Immunotherapy for Alzheimer's Disease?
,” Curr. Opin. Psychiatry
, 27
(2
), pp. 128
–137
.16.
Kohyama
, K.
, and Matsumoto
, Y.
, 2015
, “Alzheimer's Disease and Immunotherapy: What is Wrong With Clinical Trials?
,” Immunotargets Ther.
, 4
, pp. 27
–34
.17.
Panza
, F.
, Solfrizzi
, V.
, and Seripa
, D.
, 2016
, “Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
,” Biomed Res. Int.
, 2016
, p. 3245935
.18.
Kuznetsov
, I. A.
, and Kuznetsov
, A. V.
, 2015
, “A Comparison Between the Diffusion-Reaction and Slow Axonal Transport Models for Predicting Tau Distribution along an Axon
,” Math. Med. Biol.
, 32
(3
), pp. 263
–283
.19.
Kuznetsov
, I. A.
, and Kuznetsov
, A. V.
, 2016
, “Can Numerical Modeling Help Understand the Fate of Tau Protein in the Axon Terminal?
,” Comput. Methods Biomech. Biomed. Eng.
, 19
(2
), pp. 115
–125
.20.
Kuznetsov
, I. A.
, and Kuznetsov
, A. V.
, 2017
, “Simulating Tubulin-Associated Unit Transport in an Axon: Using Bootstrapping for Estimating Confidence Intervals of Best Fit Parameter Values Obtained From Indirect Experimental Data
,” Proc. R. Soc. A
, 473
(2201
), p. 20170045
.21.
Kuznetsov
, I. A.
, and Kuznetsov
, A. V.
, 2017
, “What Mechanisms of Tau Protein Transport Could Be Responsible for the Inverted Tau Concentration Gradient in Degenerating Axons?
,” Math. Med. Biol.
, 34
(1
), pp. 125
–150
.22.
Kuznetsov
, I. A.
, and Kuznetsov
, A. V.
, 2018
, “How the Formation of Amyloid Plaques and Neurofibrillary Tangles May Be Related—A Mathematical Modelling Study
,” Proc. R. Soc. A
, 474
, p. 20170777
.23.
Kuznetsov
, I. A.
, and Kuznetsov
, A. V.
, 2018
, “Simulating the Effect of Formation of Amyloid Plaques on Aggregation of Tau Protein
,” Proc. R. Soc. A
(submitted).24.
Kuznetsov
, I. A.
, and Kuznetsov
, A. V.
, 2018
, “Investigating Sensitivity Coefficients Characterizing the Response of a Model of Tau Protein Transport in an Axon to Model Parameters
,” Comput. Methods Biomech. Biomed. Eng.
(in press).25.
Blennow
, K.
, de Leon
, M. J.
, and Zetterberg
, H.
, 2006
, “Alzheimer's Disease
,” Lancet
, 368
(9533
), pp. 387
–403
.26.
Jack
, C. R.
, Jr., Knopman
, D. S.
, and Jagust
, W. J.
, 2013
, “Tracking Pathophysiological Processes in Alzheimer's Disease: An Updated Hypothetical Model of Dynamic Biomarkers
,” Lancet Neurol.
, 12
(2
), pp. 207
–216
.27.
Zi
, Z.
, 2011
, “Sensitivity Analysis Approaches Applied to Systems Biology Models
,” IET Syst. Biol.
, 5
(6
), pp. 336
–346
.28.
Rabitz
, H.
, Kramer
, M.
, and Dacol
, D.
, 1983
, “Sensitivity Analysis in Chemical-Kinetics
,” Annu. Rev. Phys. Chem.
, 34
(1
), pp. 419
–461
.29.
Scholz
, T.
, and Mandelkow
, E.
, 2014
, “Transport and Diffusion of Tau Protein in Neurons
,” Cellular Mol. Life Sci.
, 71
(16
), pp. 3139
–3150
.30.
Black
, M. M.
, Slaughter
, T.
, and Moshiach
, S.
, 1996
, “Tau is Enriched on Dynamic Microtubules in the Distal Region of Growing Axons
,” J. Neurosci.
, 16
(11
), pp. 3601
–3619
.31.
Nixon
, R. A.
, and Yang
, D.
, 2011
, “Autophagy Failure in Alzheimer's Disease-Locating the Primary Defect
,” Neurobiol. Dis.
, 43
(1
), pp. 38
–45
.32.
Nixon
, R. A.
, and Cataldo
, A. M.
, 2006
, “Lysosomal System Pathways: Genes to Neurodegeneration in Alzheimer's Disease
,” J. Alzheimers Dis.
, 9
(Suppl. 3
), pp. 277
–289
.33.
Meyer-Luehmann
, M.
, Spires-Jones
, T. L.
, and Prada
, C.
, 2008
, “Rapid Appearance and Local Toxicity of Amyloid-Beta Plaques in a Mouse Model of Alzheimer's Disease
,” Nature
, 451
(7179
), pp. 720
–724
.34.
Brown
, A.
, 2000
, “Slow Axonal Transport: Stop and Go Traffic in the Axon
,” Nat. Rev. Mol. Cell Biol.
, 1
(2
), pp. 153
–156
.35.
Vallee
, R. B.
, and Bloom
, G. S.
, 1991
, “Mechanisms of Fast and Slow Axonal-Transport
,” Annu. Rev. Neurosci.
, 14
, pp. 59
–92
.36.
Roy
, S.
, Winton
, M. J.
, and Black
, M. M.
, 2007
, “Rapid and Intermittent Cotransport of Slow Component-b Proteins
,” J. Neurosci.
, 27
(12
), pp. 3131
–3138
.37.
Hinrichs
, M. H.
, Jalal
, A.
, and Brenner
, B.
, 2012
, “Tau Protein Diffuses Along the Microtubule Lattice
,” J. Biol. Chem.
, 287
(46
), pp. 38559
–38568
.38.
Igaev
, M.
, Janning
, D.
, and Suendermann
, F.
, 2014
, “A Refined Reaction-Diffusion Model of Tau-Microtubule Dynamics and Its Application in FDAP Analysis
,” Biophys. J.
, 107
(11
), pp. 2567
–2578
.39.
Sperling
, R.
, Mormino
, E.
, and Johnson
, K.
, 2014
, “The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials
,” Neuron
, 84
(3
), pp. 608
–622
.40.
Saltelli
, A.
, Ratto
, M.
, and Andres
, T.
, 2008
, Global Sensitivity Analysis. The Primer
, Wiley
, Chichester, UK
.Copyright © 2019 by ASME
You do not currently have access to this content.
